Adagio Medical Holdings, Inc. (ADGM)
CIK 2006986 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 22.2M shares as of Aug 10, 2026 (10-Q).⊙
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Common Stock Warrants Milestone | 18.0M | $1.71 | 5y | — |
| Pipe Milestone Warrants Warrants | 12.0M | not tagged | — | — |
| Base Warrants | 7.5M | $10 | — | — |
| Common Stock Warrants Tranche B | 6.0M | not tagged | — | — |
| Common Stock Warrants Tranche C | 6.0M | not tagged | — | — |
| PIPE Pre Funded Warrants2025 | 3.0M | $0.0001 | — | — |
| Convert Warrants | 1.5M | $24 | — | — |
| Pipe Pre Funded Warrants | not tagged | $0.0001 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 11, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Convertible Securities Notes | $20.0M | $24.8M | $10 | 13% | ~2.0M sh |
If every note above converted at its tagged price: ~2.0M new shares on 22.2M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 11, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 22.2M | Aug 10, 2026 |
| + Common Stock Warrants Milestone (if exercised) | 18.0M | Oct 14, 2025 |
| + Pipe Milestone Warrants Warrants (if exercised) | 12.0M | Jun 30, 2026 |
| + Base Warrants (if exercised) | 7.5M | Jun 30, 2026 |
| + Common Stock Warrants Tranche B (if exercised) | 6.0M | Oct 31, 2025 |
| + Common Stock Warrants Tranche C (if exercised) | 6.0M | Oct 31, 2025 |
| + PIPE Pre Funded Warrants2025 (if exercised) | 3.0M | Jun 30, 2026 |
| + Convert Warrants (if exercised) | 1.5M | Jun 30, 2026 |
| + Convertible Securities Notes (if fully converted) | 2.0M | Jul 31, 2024 |
| Fully diluted estimate | 78.3M | +252.5% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $22.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 1 executed · 1 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full ADGM workspace
Free to use. No account, no card.